Search clinical trials for: Switch

Total 1017 results

Universitair Ziekenhuis Brussel
the eNose company

Completed

Evaluating a Treatment Effect in Patients With FBSS Using an Electronic Nose: a Pilot Study (NOSE)

Failed Back Surgery Syndrome

Belgium
Assistance Publique - Hôpitaux de Paris

Completed

Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital (SIC)

Rheumatoid Arthritis | Uveitis | Crohn's Disease | Spondyloarthritis

France
JW Pharmaceutical

Active, not recruiting

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM (SSUG)

Type 2 Diabetes Mellitus

Korea, Republic of
PENTA Foundation
Institut National de la Santé Et de la Recherche Médicale, France; Program... and other collaborators

Active, not recruiting

A Randomised Trial of Dolutegravir (DTG)-Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children With HIV Infection Starting First-line or Switching to Second-line ART

HIV Infection

United Kingdom, Spain, Portugal, South Africa, Thailand, Uganda, Germany, Zimbabwe
University of Minnesota

Completed

Smoking Cessation in Menthol Flavored Cigarette Smokers

Tobacco Use Disorder

United States
Pieter Dewint, MD PhD

Completed

Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders (SafE-OrBi)

Inflammatory Bowel Diseases

Belgium
University Hospital, Strasbourg, France

Unknown

Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS (SEP-RR)

Multiple Sclerosis

France
Gilead Sciences

Completed

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

HIV Infections | HIV

Canada, United States, Spain, Puerto Rico, France, Switzerland, Australia, Germany, United Kingdom, Sweden, Brazil, Austria, Thailand, Netherlands, Belgium, Dominican Republic, Portugal, Italy, Denmark, Mexico
CENTOGENE GmbH Rostock

Completed

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease (SWITCH)

Fabry Disease | Anderson-Fabry Disease | Fabry´s Disease

Argentina, Belgium, Croatia, Czechia, Denmark, France, Germany, United Kingdom
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
Bayer

Completed

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method (KYSS)

Contraception

Canada, Spain, Germany, Sweden, Mexico, Belgium, United States, Norway
Young-Suk Lim
Samsung Medical Center; Seoul National University Hospital; Korea University... and other collaborators

Completed

Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.

Chronic Hepatitis b

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

Schizophrenia | Schizoaffective Disorder

United States, Germany, Spain, Greece, Brazil, Turkey
Seoul National University Hospital

Completed

Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®)

HCC | Metastasis

Korea, Republic of
Philip Grant
Gilead Sciences

Completed

Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir (Near-Rwanda)

HIV

Rwanda
Altria Client Services LLC

Completed

Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products

Tobacco Use

United States
xjpfW
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; First Hospital... and other collaborators

Completed

A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma.

Melasma

China
Sandoz

Completed

Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa (REIN-PD)

Impulse Control Disorder

Korea, Republic of
Mario Negri Institute for Pharmacological Research
Alnylam Pharmaceuticals

Withdrawn

Eculizumab to Cemdisiran Switch in aHUS (DANCE)

Atypical Hemolytic Uremic Syndrome

Italy
NYU College of Dentistry

Active, not recruiting

Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Different Transcrestal Sinus Floor Elevation

Tooth Loss

United States
Gia Dinh People Hospital

Completed

The Effect of Early Switching From Intravenous to Oral Antibiotics Therapy

Skin and Subcutaneous Tissue Infection

Vietnam
East Coast Institute for Research
Valeritas, Inc.; Dallas Diabetes Research Center

Completed

Regular Insulin vs Rapid Insulin Delivered by V-Go

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States
Midland Research Group, Inc.
Gilead Sciences

Completed

Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1

Human Immunodeficiency Virus

United States
Hikma Pharmaceuticals LLC

Completed

Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase

Egypt
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

Schizophrenia

Hungary
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

Schizophrenia | Schizoaffective Disorder

Taiwan
Santen Pharmaceutical (Taiwan) Co., LTD

Completed

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)

Glaucoma, Primary Open Angle

Taiwan
Paris Translational Research Center for Organ Transplantation

Unknown

Long-term Outcomes After Conversion to Belatacept

Immunosuppression | Kidney Transplant Failure and Rejection | Drug Effect Prolonged | Graft Loss
Clinique du Quartier Latin
Merck Frosst Canada Ltd.

Unknown

HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance

HIV Infections

Canada, Martinique
Universitair Ziekenhuis Brussel

Completed

Sweat Gland Function in Patients With Failed Back Surgery Syndrome, Treated With Spinal Cord Stimulation

Failed Back Surgery Syndrome

Belgium
Fundación Pública Andaluza para la gestión de la...

Terminated

Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. (ADA-SWITCH)

Crohn Disease | Ulcerative Colitis

Spain
Novo Nordisk A/S

Completed

A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study (SWITCH PRO)

Diabetes Mellitus, Type 2

United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
Boryung Pharmaceutical Co., Ltd

Completed

FimasaRtan-basEd BP Targets After Drug SwitcHing (FRESH)

Essential Hypertension

Korea, Republic of
Hallym University Kangnam Sacred Heart Hospital

Completed

Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines

Hyperpigmentation | Epidermal Growth Factor | Post Inflammatory Hyperpigmentation | Nd-yttrium Aluminum Garnet Laser

Korea, Republic of
University Hospital, Montpellier

Terminated

Evolution of Dark Ideas When Introducing or Switching an Antidepressant (DEPASSE)

Current Major Depressive Disorder

France
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults

HIV-1 Infection

Spain, United States, France, Germany, United Kingdom, Italy, Canada, Australia, Belgium, Puerto Rico, Dominican Republic
Philip Morris Products S.A.

Completed

Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it

Pharmacokinetics

Russian Federation
Cynosure, Inc.

Terminated

Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma

Melasma

United States
Tun Hussein Onn National Eye Hospital

Completed

Tafluprost Preservative Free Switch Study

Primary Open Angle Glaucoma | Ocular Hypertension | Glaucoma

Malaysia
Philip Morris Products S.A.

Completed

A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

Smoking

United States
Gilead Sciences

Completed

Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years

HIV-1 Infection

Spain, United Kingdom, France, Italy, Belgium
GlaxoSmithKline
PPD

Completed

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
Gilead Sciences

Completed

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

HIV-1 Infection

Spain, United States, France, Italy, Germany, Canada, United Kingdom, Belgium, Puerto Rico, Australia
CRRF La Châtaigneraie
Hôpitaux Universitaires Paris Ile-de-Franc Ouest

Completed

Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia (RESISTAL)

Allodynia

France
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Metastatic Castration Resistant Prostate Cancer

China
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH); Pfizer

Completed

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Schizophrenia | Insulin Resistance | Metabolic Syndrome X

United States
AIO-Studien-gGmbH
Novartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study (EVINEC)

Neuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditions

Germany
Peking University People's Hospital

Unknown

A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Corticosteroid-resistant or Relapsed ITP

China
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

HIV Infections

Spain, United States, Canada, Belgium, United Kingdom, Argentina
Cairo University

Completed

Short Pulse and Q-switched ND-YAG Laser With Topical Carbon Versus Fractional CO2 Laser for Enlarged Facial Pores

Skin Lesion

Egypt

Search clinical trials for: Switch

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations